CoreCap Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9
Closed -$75 3213
2026
Q1
$75 Sell
9
-250
-97% -$2.59K ﹤0.01% 2861
2025
Q4
$3.2K Hold
259
﹤0.01% 2348
2025
Q3
$2.28K Sell
259
-2,600
-91% -$20.2K ﹤0.01% 2356
2025
Q2
$18.2K Sell
2,859
-1,825
-39% -$10.4K ﹤0.01% 1650
2025
Q1
$22.8K Sell
4,684
-3,550
-43% -$29.4K ﹤0.01% 1477
2024
Q4
$78.7K Sell
8,234
-2,500
-23% -$22.9K ﹤0.01% 1013
2024
Q3
$89.6K Sell
10,734
-13,750
-56% -$125K ﹤0.01% 962
2024
Q2
$167K Sell
24,484
-6,700
-21% -$28.8K 0.02% 395
2024
Q1
$78.9K Buy
31,184
+17,450
+127% +$39.3K ﹤0.01% 937
2023
Q4
$33K Buy
+13,734
New +$32.3K ﹤0.01% 596
2022
Q4
$106 Buy
+9
New +$139 ﹤0.01% 2308
2022
Q3
Sell
-9
Closed 944
2022
Q2
$0 Buy
+9
New +$307 ﹤0.01% 2165
2022
Q1
Sell
-9
Closed -$1K 952
2021
Q4
$1K Buy
+9
New +$407 ﹤0.01% 2103

Other funds holding EBS